ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding ImageneBio, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 41 | 33 | −8 |
| SharesConverted for a 1-for-12 split | 2.65M | 4.75M | +2.10M (+79.5%) |
| Value | $42.6M | $38.3M | −$4.21M (−9.9%) |
New holders (5)
Institutions that held ImageneBio, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RTW Investments, LP | 334,445 | $2.73M | 0.03% |
| Rangeley Capital, LLC | 15,000 | $122.3K | 0.11% |
| GWM Advisors LLC | 12,960 | $105.6K | 0.00% |
| Federated Hermes, Inc. | 204 | $1.66K | 0.00% |
| FMR LLC | 67 | $546 | 0.00% |
Sold out (13)
Institutions that held ImageneBio, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Gilead Sciences, Inc. | 348,534 | $467.1K |
| Acadian Asset Management LLC | 209,568 | $278.0K |
| Two Sigma Advisers, LP | 144,100 | $193.1K |
| State Street Corp | 92,153 | $123.5K |
| Goldman Sachs Group Inc | 66,664 | $89.3K |
| Two Sigma Investments, LP | 58,957 | $79.0K |
| Northern Trust Corp | 57,565 | $77.1K |
| Millennium Management LLC | 49,315 | $66.1K |
| Dimensional Fund Advisors LP | 38,621 | $51.8K |
| Berkshire Asset Management LLC | 20,000 | $26.8K |
| Royal Bank of Canada | 16,000 | $21.0K |
| Susquehanna International Group, LLP | 13,141 | $17.6K |
| SBI Securities Co., Ltd. | 3 | $4 |